Ipratropium bromide added to asthma treatment in the pediatric emergency department

Joseph J. Zorc, Martin V. Pusic, Jean Ogborn, Ruth Lebet, Anne K Duggan

Research output: Contribution to journalArticle

Abstract

Objective. To determine if the addition of ipratropium bromide to the emergency department (ED) treatment of childhood asthma reduces time to discharge, number of nebulizer treatments before discharge, and the rate of hospitalization. Methods. Patients >12 months of age were eligible if they were to be treated according to a standardized ED protocol for acute asthma with nebulized albuterol (2.5 mg/dose if weight

Original languageEnglish (US)
Pages (from-to)748-752
Number of pages5
JournalPediatrics
Volume103
Issue number4 I
DOIs
StatePublished - Apr 1999

Fingerprint

Ipratropium
Hospital Emergency Service
Asthma
Pediatrics
Emergency Treatment
Albuterol
Nebulizers and Vaporizers
Hospitalization
Weights and Measures
Therapeutics

Keywords

  • Adolescence
  • Albuterol
  • Asthma
  • Child
  • Critical pathway
  • Emergencies
  • Ipratropium
  • Practice guidelines
  • Randomized controlled trial

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Ipratropium bromide added to asthma treatment in the pediatric emergency department. / Zorc, Joseph J.; Pusic, Martin V.; Ogborn, Jean; Lebet, Ruth; Duggan, Anne K.

In: Pediatrics, Vol. 103, No. 4 I, 04.1999, p. 748-752.

Research output: Contribution to journalArticle

Zorc, Joseph J. ; Pusic, Martin V. ; Ogborn, Jean ; Lebet, Ruth ; Duggan, Anne K. / Ipratropium bromide added to asthma treatment in the pediatric emergency department. In: Pediatrics. 1999 ; Vol. 103, No. 4 I. pp. 748-752.
@article{a4a79656ac0a48818330eaafa9e6e5be,
title = "Ipratropium bromide added to asthma treatment in the pediatric emergency department",
abstract = "Objective. To determine if the addition of ipratropium bromide to the emergency department (ED) treatment of childhood asthma reduces time to discharge, number of nebulizer treatments before discharge, and the rate of hospitalization. Methods. Patients >12 months of age were eligible if they were to be treated according to a standardized ED protocol for acute asthma with nebulized albuterol (2.5 mg/dose if weight",
keywords = "Adolescence, Albuterol, Asthma, Child, Critical pathway, Emergencies, Ipratropium, Practice guidelines, Randomized controlled trial",
author = "Zorc, {Joseph J.} and Pusic, {Martin V.} and Jean Ogborn and Ruth Lebet and Duggan, {Anne K}",
year = "1999",
month = "4",
doi = "10.1542/peds.103.4.748",
language = "English (US)",
volume = "103",
pages = "748--752",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "4 I",

}

TY - JOUR

T1 - Ipratropium bromide added to asthma treatment in the pediatric emergency department

AU - Zorc, Joseph J.

AU - Pusic, Martin V.

AU - Ogborn, Jean

AU - Lebet, Ruth

AU - Duggan, Anne K

PY - 1999/4

Y1 - 1999/4

N2 - Objective. To determine if the addition of ipratropium bromide to the emergency department (ED) treatment of childhood asthma reduces time to discharge, number of nebulizer treatments before discharge, and the rate of hospitalization. Methods. Patients >12 months of age were eligible if they were to be treated according to a standardized ED protocol for acute asthma with nebulized albuterol (2.5 mg/dose if weight

AB - Objective. To determine if the addition of ipratropium bromide to the emergency department (ED) treatment of childhood asthma reduces time to discharge, number of nebulizer treatments before discharge, and the rate of hospitalization. Methods. Patients >12 months of age were eligible if they were to be treated according to a standardized ED protocol for acute asthma with nebulized albuterol (2.5 mg/dose if weight

KW - Adolescence

KW - Albuterol

KW - Asthma

KW - Child

KW - Critical pathway

KW - Emergencies

KW - Ipratropium

KW - Practice guidelines

KW - Randomized controlled trial

UR - http://www.scopus.com/inward/record.url?scp=0032987894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032987894&partnerID=8YFLogxK

U2 - 10.1542/peds.103.4.748

DO - 10.1542/peds.103.4.748

M3 - Article

C2 - 10103297

AN - SCOPUS:0032987894

VL - 103

SP - 748

EP - 752

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 4 I

ER -